Showing results (2011-2020 of 2,317) with videos related to
Sort By:
Pageof 232
Bioscience Reports|April 20, 2022
Inflammatory response mediates cross-talk with immune function and reveals clinical features in acute myeloid leukemiaFang-Min Zhong, Fang-Yi Yao, Jing Liu, et al.JTO Clinical and Research Reports|October 18, 2021
Pembrolizumab Plus Chemotherapy for Chinese Patients With Metastatic Squamous NSCLC in KEYNOTE-407Ying Cheng, Li Zhang, Jie Hu, et al.Drugs|December 17, 2020
Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating MutationsTony S Mok, Ying Cheng, Xiangdong Zhou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
Phase I/II Study of Tifcemalimab, an Anti-B and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung CancerYing Cheng, Jie Wang, Yan Yu, et al.Immunopharmacology and Immunotoxicology|February 14, 2016
Up-regulation of TDAG51 is a dependent factor of LPS-induced RAW264.7 macrophages proliferation and cell cycle progressionHan-Wei Jiao, Xiao-Xiao Jia, Tian-Jing Zhao, et al.BMC Cancer|April 11, 2016
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancerYan Sun, Ying Cheng, Xuezhi Hao, et al.Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|March 16, 2012
[Double balloon endoscopy in diagnosis of patients with obscure gastrointestinal bleeding]Li-hua Chen, Hai-jun Cao, Wen-guo Chen, et al.Biomaterials|April 11, 2009
The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticlesDong-Ming Huang, Jong-Kai Hsiao, Ying-Chun Chen, et al.The Lancet. Oncology|January 15, 2026
Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trialLiang Zhang, Xiqin Zhang, Lin Wu, et al.Cell|May 5, 2015
N6-methyladenine DNA modification in DrosophilaGuoqiang Zhang, Hua Huang, Di Liu, et al.Pageof 232